Mayapada Healthcare presented international advances in cancer treatment through robotic surgery, precision diagnostics, and personalized oncology services at Mayapada HOPE 2026 in Jakarta (08/11). The event, held under the theme "Shaping the Future of Cancer Care: Precision in Every Decision," brought together international oncology experts, Mayapada Hospital specialists, and strategic partners to discuss developments in modern cancer care.

The forum highlighted precision oncology, nuclear medicine, minimally invasive robotic surgery, and targeted cancer therapies. It also showcased the capabilities of Mayapada Hospital's Oncology Center in providing integrated cancer services through multidisciplinary medical collaboration and advanced technology.

Mayapada Healthcare Advances Precision Cancer Treatment in Indonesia

Modern cancer treatment increasingly focuses on precision oncology, an approach that selects treatment based on the characteristics of each patient's cancer and overall health condition.

At Mayapada Hospital, this approach is supported by its Oncology Center and multidisciplinary Tumor Board, which brings together specialists and subspecialists to determine appropriate treatment strategies.

Mayapada HOPE 2026 covered several developments in oncology, including international precision oncology practices, molecular pathology, PET/CT and SPECT/CT diagnostics, robotic surgery, targeted therapy, immunotherapy, radiotherapy, and multidisciplinary cancer care. Discussions also addressed developments in breast, urological, and digestive cancer treatment.

Navin Sonthalia, President Director and CEO of Mayapada Healthcare, said the adoption of modern oncology practices is part of the company's strategy to make internationally aligned cancer services more accessible to Indonesians.

"Indonesia has doctors with excellent expertise. Our role is to ensure that their expertise is supported by the latest medical technology, multidisciplinary collaboration, and access to developments in global clinical practices. Through Mayapada HOPE 2026, we demonstrate the capabilities of Mayapada Hospital's Oncology Center in delivering increasingly advanced, precise, and personalized cancer treatment, allowing people to receive quality care in Indonesia," Navin said.

Precision Oncology and Robotic Surgery Support Personalized Cancer Care

Precision oncology recognizes that patients with the same type of cancer may require different treatments. Decisions must consider the cancer stage, tumor characteristics, and the patient's overall health condition.

Prof. Dr. dr. Ikhwan Rinaldi, a member of the Tumor Board at Mayapada Hospital's Oncology Center, explained that multidisciplinary collaboration is essential in determining the most appropriate treatment for each patient.

"Two patients with the same type of cancer do not necessarily need the same treatment. Treatment decisions must consider the stage, tumor characteristics, and the patient's health condition. This is why multidisciplinary collaboration through a Tumor Board is essential in determining the most appropriate treatment strategy, ranging from surgery and chemotherapy to targeted therapy, immunotherapy, or a combination of treatments based on the patient's needs," he explained.

Robotic surgery is another development supporting modern cancer treatment. Minimally invasive procedures use smaller incisions and allow doctors to perform complex operations with clearer visualization and more precise instrument control.

Prof. (Dr.) Sanjai Kumar Addla, who has performed more than 1,000 robotic surgical procedures for urological cases, highlighted the importance of combining medical expertise with advanced technology.

"Indonesia does not lack excellent doctors. Their expertise needs to be supported by the latest medical technology so they can provide treatment in line with global standards. Robotic surgery is no longer a technology of the future but has become part of modern surgical practice today. Its availability at Mayapada Hospital allows doctors to perform complex procedures with clearer visualization and more precise instrument control, while making globally aligned surgical advances increasingly accessible to Indonesian patients," he said.

PET Scans, SPECT Scans and Theranostics Advance Cancer Diagnosis

Nuclear medicine and theranostics are also important components of precision cancer treatment. These technologies help doctors understand cancer conditions, assess disease spread, and determine more targeted treatment options.

During Mayapada HOPE 2026, Dr. Ngam Pei Ing discussed these developments in a session titled "Advancing Precision Cancer Care Through Theranostics."

Positron Emission Tomography (PET) scans and Single Photon Emission Computed Tomography (SPECT) scans provide information that helps doctors assess cancer conditions and determine appropriate treatment strategies. Theranostics also creates opportunities for more targeted treatment based on individual disease characteristics.

Dr. Ngam Pei Ing, from National University Hospital in Singapore, explained the importance of these technologies in expanding access to advanced cancer services in Indonesia.

"Positron Emission Tomography (PET) scans and Single Photon Emission Computed Tomography (SPECT) scans help doctors understand the condition and spread of cancer as a basis for determining the appropriate treatment. Meanwhile, theranostics creates opportunities for more targeted therapy based on the characteristics of each patient's disease. The availability of PET and SPECT scans at Mayapada Hospital is an important step towards expanding access for Indonesian people to advanced diagnostics and supporting increasingly precise cancer treatment, allowing services aligned with global oncology practices to be obtained domestically," she explained.

Mayapada Hospital Demonstrates Robotic Breast Cancer Surgery

Mayapada Hospital Jakarta Selatan successfully performed a robot-assisted breast cancer removal procedure, known as a mastectomy, using the da Vinci Xi robotic system on the same day as the Mayapada HOPE 2026 event.

The procedure was led by dr. Bayu Brahma, Sp.B.Subsp.Onk(K). Its planning involved Clinical Associate Prof. Mok Chi Wei, a surgeon from Changi General Hospital in Singapore who also participated as a speaker at the event.

The operation was performed through a single small incision. According to Mayapada Healthcare, the procedure helped make surgical scars less visible, supported the preservation of breast skin and the nipple, and helped maintain the patient's appearance and confidence after surgery.

During a panel discussion titled "The Evolution of Cancer Surgery: Advancing Patient Outcomes Through Innovation," Prof. Mok Chi Wei discussed the contribution of minimally invasive and robotic technology to cancer surgery.

"Advances in minimally invasive surgery and robotic technology have brought significant progress to cancer treatment, including breast cancer surgery, which can now be performed with greater precision while helping preserve breast shape and maintain patients' quality of life. The successful robotic surgery procedure at Mayapada Hospital demonstrates the clinical capabilities of its Oncology Center team in applying modern surgical innovations in line with developments in global oncology practices," he said.

Multidisciplinary Care Supports Personalized Cancer Treatment

Mayapada Hospital's approach to precision oncology also involves integrated care throughout the patient's treatment journey. The hospital uses a multidisciplinary Tumor Board, standardized clinical pathways, and Patient Navigators to support patients and their families.

The treatment process begins with medical examinations to assess the patient's condition, cancer stage, and tumor characteristics. Specialists and subspecialists then discuss the findings through the Tumor Board to determine an appropriate treatment strategy.

The selected treatment follows standardized clinical pathways, while Patient Navigators provide assistance to patients and their families at every stage of care. The hospital also monitors service quality to support the optimization of patient outcomes.

dr. Dini Handayani, Chief Medical Officer of Mayapada Healthcare, emphasized the importance of coordinating medical decisions and patient care.

"Precision in cancer treatment means ensuring that every medical decision is right for the right patient at the right time. Through the Tumor Board, standardized care pathways, and Patient Navigator support, we connect every stage of treatment, from examination and therapy selection to follow-up monitoring, so patients receive personalized and continuous care. This is the essence of Mayapada HOPE 2026: bringing global advances in oncology into tangible benefits for treatment outcomes and the quality of life of Indonesian patients," she said.

PHOTO: MAYAPADA HOSPITAL

This article was created with AI assistance.

We make every effort to ensure the accuracy of our content, some information may be incorrect or outdated. Please let us know of any corrections at [email protected].